Healthcare Disparities in the Treatment and Outcomes of Hepatocellular Carcinoma in South Africa
In the public sector, patients present with more advanced HCC, which limits their access to curative-intended therapies, resulting in lower survival. Patients treated with curative-intended therapies have similar survival rates in the public and private sectors. With the introduction of universal health coverage through the National Health Insurance program in South Africa, these data highlight the gaps in HCC care in the public sector, where health initiatives such as HBV vaccination, early treatment of HBV, patient education, and screening of at-risk patients should be prioritized.
Authors
- C Wendy Spearman (ORCID: https://orcid.org/0000-0003-3199-301X)
- J E J Krige (ORCID: https://orcid.org/0000-0002-7057-9156)
- Mark Wayne Sonderup (ORCID: https://orcid.org/0000-0001-7128-8329)
- Eduard Jonas (ORCID: https://orcid.org/0000-0003-0123-256X)
- C. Kloppers (ORCID: https://orcid.org/0000-0003-2438-6879)
- M. Bernon (ORCID: https://orcid.org/0000-0002-7967-8548)
- Kobus Venter (ORCID: https://orcid.org/0000-0001-6910-1756)
- U. Kotze (ORCID: https://orcid.org/0000-0003-1405-474X)
- Sanju Sobnach (ORCID: https://orcid.org/0000-0002-4456-2115)
- Muhammad Emmamally (ORCID: https://orcid.org/0009-0005-2148-685X)
- Rufaida Khan
Institutions
- University of Cape Town (ZA)
Publication Details
- Journal
- World Journal of Surgery
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1002/wjs.12559
- Citations
- 3
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 3.97